Empagliflozin and Metformin
Strength(s):
12.5mg + 1000mg, 5mg + 500mg
Dosage
Form: Tablets
Description:
This fixed-dose combination of Empagliflozin (a SGLT2 inhibitor) and Metformin (a biguanide) is used to improve glycemic control in adults with type 2 diabetes, especially those not adequately managed by Metformin alone.
Key Features:
- Dual-action blood sugar control
- Promotes glucose excretion via urine
- Aids in weight management and blood pressure reduction
Precautions:
Not recommended for patients with severe kidney disease. Monitor for signs of lactic acidosis or urinary tract infections.